11
Views
1
CrossRef citations to date
0
Altmetric
Review Article

Clinical Risk Management of the Rapid-Cycling Bipolar Patient

Pages 245-254 | Received 14 May 1996, Accepted 12 Aug 1996, Published online: 03 Jul 2009

References

  • McElroy S, Keck P E. Rapid cycling. Current psychiatric therapy, D L Dunner. Saunders, Philadelphia 1993; 226–31
  • Altshuler L L, Post R M, Leverich G S, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995; 152: 1130–8
  • Anonymous. Benefacts: a message from the APA-sponsored professional liability insurance program. Psychiatr News Apr, 1996; 19: 26
  • Goodwin F K, Jamison K R. Manic-depressive illness. Oxford University Press, New York 1990
  • Kukopulos A, Caliari B, Tundo A, Minnai G, Floris G, Reginaldi D, et al. Rapid cyclers, temperament, and antidepressants. Compr Psychiatry 1983; 24: 249–58
  • American Psychiatric Association. Rapid-cycling specifier. Diagnostic and statistical manual of mental disorders. 4th ed. American Psychiatric Press, Washington, DC 1994; 390–1
  • Wehr T A, Sack D A, Rosenthal N E, Cowdry R W. Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry 1988; 145: 179–84
  • Fawcett J, Scheftner W, Clark D, Hedeker D, Gibbons R, Coryell W. Clinical predictors of suicide in patients with major affective disorders: a controlled prospective study. Am J Psychiatry 1987; 144: 35–40
  • Dunner D L, Fieve R R. Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 1974; 30: 229–33
  • Alarcon R D. Rapid cycling affective disorders: a clinical review. Compr Psychiatry 1985; 26: 522–40
  • Calabrese J R, Woyshville M J. A medication algorithm for treatment of bipolar rapid cycling?. J Clin Psychiatry 1995; 56: 11–8, (suppl 3)
  • Keck P. The biology and treatment of rapid cycling bipolar disorders. Presented at the Caribbean Psychopharmacology Congress, St Martin, February, 171995
  • Fawcett J. Suicide risk factors in panic disorder. J Clin Psychiatry 1992; 53: 9–13
  • Brady K T, Sonne S C. The relationship between substance abuse and bipolar disorder. J Clin Psychiatry 1995; 56: 19–24, (suppl 3)
  • Simon R I, Sadoff R L. Psychiatric malpractice: cases and comments for clinicians. American Psychiatric Press, Washington, DC 1992
  • Simon R I. Clinical psychiatry and the law. 2nd ed. American Psychiatric Press, Washington, DC 1992
  • Simon R I. Innovative psychiatric therapies and legal uncertainty: a survival guide for clinicians. Psychiatr Ann 1993; 23: 473–9
  • Macbeth J E, Wheeler A M, Sither J W, Onek J N. Legal and risk management issues in the practice of psychiatry. Malpractice. Psychiatrists' Purchasing Group, Washington, DC 1994
  • Anonymous. Advisory committee recommends mania indication for divalproex sodium. Psychiatr Times 1995; 6, Mar
  • Marangell L B, Yudofsky S C. Developments in the treatment of bipolar disorder. Prim Psychiatry 1995; 2: 32–41
  • Bender K J. NIMH seeks improved pharmacotherapy for children. Psychiatr Times 1995; 40, Mar
  • , Ramon v Farr, 770 P2d 131 (Utah 1989)
  • , Schloendorff v Society of New York Hospital, 211 NY 125, 105 NE 92 (1914)
  • , Bing v Thunig, 2 NY2d 656, 143 NE2d 3, 163 NYS2d 3 (1957)
  • , Natanson v Kline, 186 Kan 393, 350 P2d 1093 (1960)
  • , Canterbury v Spence, 464 F2d 772 (DC Cir 1972)
  • , Spence v Canterbury, 409 US 1064 (1972)
  • , Cobbs v Grant, 8 Cal 3d 229, 104 Cal Rptr 505, 502 P2d 1 (1972)
  • Gibbs R F. Informed consent: what it is and how to obtain it. Leg Aspects Med Pract 1987; 15: 1–4, (Aug)
  • , Klein v Biscup, 1996 Ohio App. Lexis 511
  • , Hondroulis v Schuhmacher, 553 So 3d 398 (La 1988)
  • , Public Health Trust of Dade County v Valcin, 507 So 2d 596 (Fla 1987)
  • Appelbaum P S, Gutheil T G. Clinical handbook of psychiatry and the law. 2nd ed. Williams & Wilkins, Baltimore 1991
  • Brakel S J, Parry J, Weiner B A. The mentally disabled and the law. 3rd ed. American Bar Foundation, Chicago 1985
  • Buda M, Tsuang M T. The epidemiology of suicide: implications for clinical practice. Suicide over the life cycle, S J Blumenthal, D J Kupfer. American Psychiatric Press, Washington, DC 1990; 17–37
  • Tardiff K. Violence by psychiatric patients. American Psychiatric Press review of clinical psychiatry and the law, vol 2, R I Simon. American Psychiatric Press, Washington, DC 1991; 175–233
  • Simon R I. Clinical risk management of suicidal patients: assessing the unpredictable. American Psychiatric Press review of clinical psychiatry and the law, vol 3, R I Simon. American Psychiatric Press, Washington, DC 1992; 3–63
  • Fawcett J. Predictors of early suicide: identification and appropriate intervention. J Clin Psychiatry 1988; 49: 7–9, (10 suppl)
  • Fawcett J, Scheftner W A, Fogg L, Clark D C, Young M A, Hedeker D, et al. Time-related predictors of suicide in major affective disorder. Am J Psychiatry 1990; 147: 1189–94
  • Teicher M H, Glod C, Cole J. Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 1990; 52: 294–9
  • Mann J, Kapur S. The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy. Arch Gen Psychiatry 1991; 48: 1027–33
  • Fava M, Rosenbaum J F. Suicidality and fluoxetine: is there a relationship?. J Clin Psychiatry 1992; 52: 108–11
  • Warshaw M G, Keller M B. The relationship between fluoxetine use and suicidal behavior in 654 subjects with anxiety disorders. J Clin Psychiatry 1996; 57: 158–66
  • Fentress v Shea Communications, Inc. 1990, Jefferson [Kentucky] Circuit Court, 90-CI-06033
  • Blumenthal S J. An overview and synopsis of risk factors, assessment, and treatment of suicidal patients over the life cycle. Suicide over the life cycle: risk factors, assessment, and treatment of suicidal patients, S J Blumenthal, D J Kupfer. American Psychiatric Press, Washington, DC 1990; 685–733
  • , Tarasoff v Regents of University of California, 237 Cal 3d 425, 551 P2d 334 (1976)
  • Appelbaum P S, Zonana H, Bonnie R, Roth L H. Statutory approaches to limiting psychiatrists' liability for their patients' violent acts. Am J Psychiatry 1989; 146: 821–8
  • Slovenko R. The therapist's duty to warn or protect endangered third persons. J Psychiatry Law 1988; 16: 134–209
  • Beck J C. Current status of the duty to protect. Confidentiality versus the duty to protect: foreseeable harm in the practice of psychiatry, J C Beck. American Psychiatric Press, Washington, DC 1990; 9–12
  • , Underwood v United States, 356 F2d 92 (5th Cir 1966)
  • Sparr L F, Drummond D J. Risk management in Veterans Administration mental health clinics. American Psychiatric Press review of clinical psychiatry and the law, vol 3, R I Simon. American Psychiatric Press, Washington, DC 1992; 67–97
  • Zeldow P B, Taub H A. Evaluating psychiatric discharge and aftercare in a VA medical center. Hosp Community Psychiatry 1981; 32: 57–8
  • Roy A. Risk factors for suicide in psychiatric patients. Arch Gen Psychiatry 1982; 39: 1089–95
  • Simon R I. Concise guide to psychiatry and law for clinicians. American Psychiatric Press, Washington, DC 1992
  • Council on Ethical and Judicial Affairs. Council report: ethical issues in managed care. JAMA 1995; 273: 330–5
  • , Wickline v California, 183 Cal App 3d 1175, 228 Cal Rptr 661 (Cal Ct App 1986)
  • , Wilson v Blue Cross of Southern California, 222 Cal App 3d 660 (1990)
  • , Sarchett v Blue Cross of California, 729 P2d 267 (Cal 1987)
  • American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 1994; 151: 1–36, (12 suppl)
  • Hirshfeld E B. Practice parameters and the malpractice liability of physicians. JAMA 1990; 263: 1556–62
  • Kellie S E, Kelly J T. Appropriateness criteria: potential usefulness in practice parameters (background report). Office of Quality Assurance, American Medical Association, Chicago 1990
  • Hirshfeld E B. Should practice parameters be the standard of care in malpractice litigation?. JAMA 1991; 266: 2886–91
  • Daly M. Attacking defensive medicine through the utilization of practice parameters: panacea or placebo for the health care reform movement?. J Leg Med 1995; 16: 101–32

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.